Thymidylate Synthase: A Predictive Biomarker in Resected Colorectal Liver Metastases Receiving 5-FU Treatment

References

• Brody H . Colorectal cancer. Nature521(7551), S1 (2015).
   PubMed Web of Science ®Google Scholar
• McGuire S . World Cancer Report 2014. Geneva, Switzerland: WHO, International Agency for Research on Cancer, WHO Press, 2015. Adv. Nutr.7(2), 418–419 (2016).
   PubMed Web of Science ®Google Scholar
• Biasco G , DerenziniE, GraziGet al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat. Rev.32(3), 214–228 (2006).
   PubMed Web of Science ®Google Scholar
• Pulitano C , CastilloF, AldrighettiLet al. What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford)12(4), 244–249 (2010).
   PubMed Web of Science ®Google Scholar
• Tomlinson JS , JarnaginWR, DematteoRPet al. Actual 10 year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol.25(29), 4575–4580 (2007).
   PubMed Web of Science ®Google Scholar
• Bronte G , RolfoC, PeetersM, RussoA. How to find the Ariadne’s thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?Expert Opin. Biol. Ther.14(6), 743–748 (2014).
   PubMed Web of Science ®Google Scholar
• Fong Y , FortnerJ, SunRL, BrennanMF, BlumgartLH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg.230(3), 309–318; discussion 318–321 (1999).
   PubMed Web of Science ®Google Scholar
• Malik HZ , PrasadKR, HalazunKJet al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann. Surg.246(5), 806–814 (2007).
   PubMed Web of Science ®Google Scholar
• Rees M , TekkisPP, WelshFK, O’RourkeT, JohnTG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann. Surg.247(1), 125–135 (2008).
   PubMed Web of Science ®Google Scholar
• Spelt L , NilssonJ, AnderssonR, AnderssonB. Artificial neural networks – a method for prediction of survival following liver resection for colorectal cancer metastases. Eur. J. Surg. Oncol.39(6), 648–654 (2013).
   PubMed Web of Science ®Google Scholar
• Ivanecz A , PotrcS, HorvatM, JagricT, GadzijevE. The validity of clinical risk score for patients undergoing liver resection for colorectal metastases. Hepatogastroenterology56(94–95), 1452–1458 (2009).
   PubMedGoogle Scholar
• Reissfelder C , RahbariNN, KochMet al. Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann. Surg. Oncol.16(12), 3279–3288 (2009).
   PubMed Web of Science ®Google Scholar
• Santi DV , McHenryCS, SommerH. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry13(3), 471–481 (1974).
   PubMed Web of Science ®Google Scholar
• Berger SH , JenhCH, JohnsonLF, BergerFG. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol. Pharmacol.28(5), 461–467 (1985).
   PubMed Web of Science ®Google Scholar
• Johnston PG , DrakeJC, TrepelJ, AllegraCJ. Immunological quantitation of thymidylate synthase using the monoclonal-antibody TS 106 in 5-fluorouracil-sensitive and 5-fluorouracil-resistant human cancer cell-lines. Cancer Res.52(16), 4306–4312 (1992).
   PubMed Web of Science ®Google Scholar
• Bai W , WuY, ZhangP, XiY. Correlations between expression levels of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase, and efficacy of 5-fluorouracil-based chemotherapy for advanced colorectal cancer. Int. J. Clin. Exp. Pathol.8(10), 12333–12345 (2015).
   PubMed Web of Science ®Google Scholar
• Ishikawa Y , KubotaT, OtaniYet al. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer. Anticancer Res.19(6C), 5635–5640 (1999).
   PubMed Web of Science ®Google Scholar
• Johnston PG , LenzHJ, LeichmanCGet al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res.55(7), 1407–1412 (1995).
   PubMed Web of Science ®Google Scholar
• Peters GJ , van der WiltCL, van GroeningenCJ, SmidK, MeijerS, PinedoHM. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J. Clin. Oncol.12(10), 2035–2042 (1994).
   PubMed Web of Science ®Google Scholar
• Wakasa K , KawabataR, NakaoSet al. Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells. PLoS ONE10(4), e0123076 (2015).
   PubMed Web of Science ®Google Scholar
• Wang T , WangL, QianX, YuL, DingY, LiuB. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites. Cancer Invest.29(2), 130–136 (2011).
   PubMed Web of Science ®Google Scholar
• Danenberg PV , HeidelbergerC, MulkinsMA, PetersonAR. The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cells. Biochem. Biophys. Res. Commun.102(2), 654–658 (1981).
   PubMed Web of Science ®Google Scholar
• Danenberg PV , LangenbachRJ, HeidelbergerC. Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. Biochemistry13(5), 926–933 (1974).
   PubMed Web of Science ®Google Scholar
• Kufe DW , MajorPP, EganEM, LohE. 5-fluoro-2′-deoxyuridine incorporation in L1210 DNA. J. Biol. Chem.256(17), 8885–8888 (1981).
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP . STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK… and CONSORT: for whom does the guideline toll?J. Clin. Epidemiol.62(6), 594–596 (2009).
   PubMed Web of Science ®Google Scholar
• Moher D , LiberatiA, TetzlaffJ, AltmanDG, PRISMAGroup. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg.8(5), 336–341 (2010).
   PubMed Web of Science ®Google Scholar
• Verbeek J . MOOSE CONSORT STROBE and MIAME STARD REMARK or how can we improve the quality of reporting studies. Scand. J. Work Environ. Health34(3), 165–167 (2008).
   PubMed Web of Science ®Google Scholar
• Parmar MK , TorriV, StewartL. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat. Med.17(24), 2815–2834 (1998).
   PubMed Web of Science ®Google Scholar
• Aschele C , DebernardisD, BandelloniRet al. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil. Ann. Oncol.13(12), 1882–1892 (2002).
   PubMed Web of Science ®Google Scholar
• Aschele C , DebernardisD, TunesiG, MaleyF, SobreroA. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil. Clin. Cancer Res.6(12), 4797–4802 (2000).
   PubMed Web of Science ®Google Scholar
• Backus HH , van RielJM, van GroeningenCJet al. Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer. Ann. Oncol.12(6), 779–785 (2001).
   PubMed Web of Science ®Google Scholar
• Bathe OF , FranceschiD, LivingstoneAS, MoffatFL, TianE, ArdalanB. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. Cancer J. Sci. Am.5(1), 34–40 (1999).
   PubMed Web of Science ®Google Scholar
• Corsi DC , CiaparroneM, ZannoniGet al. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer. Eur. J. Cancer38(4), 527–534 (2002).
   PubMed Web of Science ®Google Scholar
• D’Angelica M , AmmoriJ, GonenMet al. Folate receptor-alpha expression in resectable hepatic colorectal cancer metastases: patterns and significance. Mod. Pathol.24(9), 1221–1228 (2011).
   PubMed Web of Science ®Google Scholar
• Davies MM , JohnstonPG, KaurS, Allen-MershTG. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine. Clin. Cancer Res.5(2), 325–328 (1999).
   PubMed Web of Science ®Google Scholar
• Etienne MC , ChazalM, Laurent-PuigPet al. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J. Clin. Oncol.20(12), 2832–2843 (2002).
   PubMed Web of Science ®Google Scholar
• Gonen M , HummerA, ZervoudakisAet al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J. Clin. Oncol.21(3), 406–412 (2003).
   PubMed Web of Science ®Google Scholar
• Hillenbrand A , FormentiniA, StaibLet al. A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy. Eur. J. Surg. Oncol.30(4), 407–413 (2004).
   PubMed Web of Science ®Google Scholar
• Hosokawa A , YamadaY, ShimadaYet al. Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil. Int. J. Clin. Oncol.9(5), 388–392 (2004).
   PubMedGoogle Scholar
• Idelevich E , GreifF, MavorEet al. Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer. Chemotherapy55(2), 76–82 (2009).
   PubMed Web of Science ®Google Scholar
• Ishida H , SadahiroS, TajimaT, MakuuchiH. [Immunohistologic evaluation of TS, DPD, and p53 protein expression in patients with colorectal cancer having liver and pulmonary metastases]. Nihon Rinsho61(Suppl. 7), 233–236 (2003).
   PubMedGoogle Scholar
• Ivanecz A , KavalarR, PalfyMet al. Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases. HPB (Oxford)16(3), 235–242 (2014).
   PubMed Web of Science ®Google Scholar
• Kaira K , OkumuraT, OhdeYet al. Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer. Anticancer Res.31(9), 2763–2771 (2011).
   PubMed Web of Science ®Google Scholar
• Kataoka K , KanazawaA, NakajimaA, YamaguchiA, ArimotoA. Prognostic value of biomarkers in metastatic colorectal cancer patients. J. Surg. Res.194(2), 343–350 (2015).
   PubMed Web of Science ®Google Scholar
• Kornmann M , LinkKH, LenzHJet al. Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett.118(1), 29–35 (1997).
   PubMed Web of Science ®Google Scholar
• Lassmann S , TangL, CapanuMet al. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology133(6), 1831–1839 (2007).
   PubMed Web of Science ®Google Scholar
• Leichman CG , LenzHJ, LeichmanLet al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol.15(10), 3223–3229 (1997).
   PubMed Web of Science ®Google Scholar
• Libra M , NavolanicPM, TalaminiRet al. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy. BMC Cancer4, 11 (2004).
   PubMed Web of Science ®Google Scholar
• Link KH , KornmannM, ButzerUet al. Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy. Cancer89(2), 288–296 (2000).
   PubMed Web of Science ®Google Scholar
• Lopez-Gomez M , Moreno-RubioJ, Suarez-GarciaIet al. SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases. Clin. Transl. Oncol.17(2), 133–138 (2015).
   PubMed Web of Science ®Google Scholar
• Maithel SK , GonenM, ItoHet al. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery151(2), 162–170 (2012).
   PubMed Web of Science ®Google Scholar
• Saw RP , KooreyD, PainterD, GallagherPJ, SolomonMJ. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Br. J. Surg.89(11), 1409–1415 (2002).
   PubMed Web of Science ®Google Scholar
• Shirota Y , StoehlmacherJ, BrabenderJet al. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J. Clin. Oncol.19(23), 4298–4304 (2001).
   PubMed Web of Science ®Google Scholar
• Strnad R , RyskaM, BelinaF, LangerD, NovotnyJ, LudvikovaM. [Prediction of treatment outcome after adjuvant loco-regional chemotherapy following liver resection for colorectal metastases – preliminary results]. Rozhl. Chir.85(3), 124–128 (2006).
   PubMedGoogle Scholar
• Wang TL , DiazLAJr, RomansKet al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc. Natl Acad. Sci. USA101(9), 3089–3094 (2004).
   PubMed Web of Science ®Google Scholar
• Watson RG , MuhaleF, ThorneLBet al. Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy. Eur. J. Cancer46(18), 3358–3364 (2010).
   PubMed Web of Science ®Google Scholar
• Yamane T , SeshimoA, KameokaS. Analysis of the mRNA expression levels of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD) and orotate phosphoribosyl transferase (OPRT) in liver metastases from colorectal cancer. Hepatogastroenterology60(122), 291–295 (2013).
   PubMedGoogle Scholar
• Chen Y , YiC, LiuL, LiB, WangY, WangX. Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data. Int. J. Biol. Markers27(3), e203–e211 (2012).
   PubMed Web of Science ®Google Scholar
• Popat S , MatakidouA, HoulstonRS. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J. Clin. Oncol.22(3), 529–536 (2004).
   PubMed Web of Science ®Google Scholar
• Qiu LX , TangQY, BaiJLet al. Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fluoropyrimidine-based chemotherapy: evidence from 24 studies. Int. J. Cancer123(10), 2384–2389 (2008).
   PubMed Web of Science ®Google Scholar
• Liang J , FazioV, LaveryIet al. Primacy of surgery for colorectal cancer. Br. J. Surg.102(7), 847–852 (2015).
   PubMed Web of Science ®Google Scholar
• Pramateftakis MG , KanellosD, TekkisPP, TouroutoglouN, KanellosI. Rectal cancer: multimodal treatment approach. Int. J. Surg. Oncol. 2012, 279341 (2012).
   PubMedGoogle Scholar
• Khoo E , O’NeillS, BrownE, WigmoreSJ, HarrisonEM. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal–liver metastases. HPB (Oxford)18(6), 485–493 (2016).
   PubMed Web of Science ®Google Scholar
• Nordlinger B , SorbyeH, GlimeliusBet al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, Phase 3 trial. Lancet Oncol.14(12), 1208–1215 (2013).
   PubMed Web of Science ®Google Scholar
• Kanat O , GewirtzA, KemenyN. What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer. J. Gastrointest. Oncol.3(2), 130–138 (2012).
   PubMedGoogle Scholar
• Maher B , RyanE, LittleM, BoardmanP, StedmanB. The management of colorectal liver metastases. Clin. Radiol.72(8), 617–625 (2017).
   PubMed Web of Science ®Google Scholar
• Di Nicolantonio F , MercerSJ, KnightLAet al. Cancer cell adaptation to chemotherapy. BMC Cancer5, 78 (2005).
   PubMed Web of Science ®Google Scholar